Immunisation Information Systems in the EU and EEA

Immunisation information systems (IIS) are defined as confidential, population-based, computerised databases that record all immunisation doses administered by participating providers to persons residing within a given geopolitical area. At the point of clinical care, they support practitioner decision-making in ensuring appropriate individual vaccination and adherence to applicable policies. At population level, IIS provide aggregate data on vaccinations for use in surveillance and programme operations, and in guiding public health action to improve vaccination rates and reduce vaccine-preventable diseases.

The European Council conclusions on vaccinations from both 2011 and 2014 recommend the adoption of such systems and the World Health Organization's European Vaccine Action Plan 2015–2020 recognises IIS as 'an integral part of well-functioning health systems'. IIS have the potential to improve performance of vaccination programmes and to increase vaccine uptake, but the design, development and implementation of such systems can be challenging for national programme managers. The European Centre for Disease Prevention and Control (ECDC) is currently running activities to support the Member States in establishing IIS. One important initial activity was to gather information about the implementation level and the functionalities of existing immunisation information systems in European Union/European Economic Area (EU/EEA) countries. To do this, ECDC, in close collaboration with subject-matter experts, developed surveys on IIS status and functionalities in EU/EEA countries.

Download: Immunisation Information Systems in the EU and EEA (1.282 KB).

Download from eHealthNews.eu: Immunisation Information Systems in the EU and EEA (2.282 KB).

Most Popular Now

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Abbott to Launch the NeuroSphere™ myPath…

Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...

Philips and Merck Partner to Advance Per…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced a multi-year partnership with Merck, a leading science and technology company, to develop clinical-grade digital solutions for...